Dr. Gerald Batist

Dr. Gerald Batist, Director of the Segal Cancer Centre and Deputy Director of the Lady Davis Institute at the JGH, has received the 2019 Award for Exceptional Leadership in Cancer Research from the Canadian Cancer Research Alliance.

In 1981, Hope & Cope was launched under the auspices of the JGH Auxiliary to use specially trained volunteers (many of whom were cancer survivors) to support and counsel cancer patients and their families.

It is with deep sorrow that we mourn the sudden and tragic passing of Dr. Mark A. Wainberg, one of the world’s pre-eminent experts on HIV/AIDS and its treatment.

The Segal Cancer Centre is taking “one small step” that could lead to “one giant leap” in a metaphorical moonshot to conquer cancer.

Canadian and Israeli strategies for controlling budgets and reducing waiting times were compared and explored on November 23, 2016, during a visit to the JGH by Rabbi Yaakov Litzman, Israel’s Minister of Health.

In the space of just a few months this past spring, Dr. Gerald Batist was appointed a Member of the Order of Canada and a Knight of the National Order of Quebec.

The Jewish General Hospital’s French connection has been strengthened with the visit of six senior members of staff from the Regional Cancer Centre of the University Hospital Centre of Poitiers.

A new electronic scheduler that manages appointments has dramatically cut the time that patients wait before receiving their first chemotherapy session in the Segal Cancer Centre at the JGH.

Dr. Roberta Shear, a member of the JGH Department of Obstetrics and Gynecology since 2000, has been named Director of Obstetrics, the Family Birthing Centre and Obstetrical Ultrasound.

The effort to find new biomarkers for cancer has received a major boost with the recent arrival at Lady Davis Institute of Dr. Christoph Borchers and the development of the first pan-Canadian proteomics program.